The European Commission’s proposals to extend the transition deadlines for legacy products in the context of the Medical Device Regulation and remove the sell-off date for products under both the MDR and In Vitro Diagnostics Regulation were adopted formally by the EU Council during a meeting on 7 March.
The unanimous vote by all 27 member states took place during a meeting of the Council of the European Union...